Evidence map›Paper›PMID 42730318›Full record

ArticleInfection and drug resistance2026

Analysis of the Etiology and Antibiotic Resistance of Bacterial Infections in Newborns in a Chinese Tertiary Hospital: From 2019 to 2024.

Haoan Sun, Jiangrong Luo

Abstract read
In one paragraph

Article in Infection and drug resistance, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Haoan SunSchool of Medicine, University of Electronic Science and Technology of China, Chengdu, Sichuan, People's Republic of China.
Jiangrong LuoDepartment of Anesthesiology, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, Sichuan, People's Republic of China.ORCID 0000-0001-9699-2451

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: This study aims to investigate the pathogen spectrum and antimicrobial resistance trends in hospitalized infants in the neonatal intensive care unit (NICU) of our hospital (a major hospital in China) from 2019 to 2024. The evolving pathogen spectrum highlights the need for precise local diagnostic strategies based on surveillance data. The high prevalence of antimicrobial resistance calls for the optimization of empirical antimicrobial therapy and stringent antimicrobial stewardship. Additionally, this study provides evidence-based recommendations for cost-effective antimicrobial resistance control in resource-limited regions globally. Methods: A retrospective analysis of neonatal infection clinical data from the past five years was performed, focusing on the distribution of major pathogens and the evolution of antimicrobial resistance across the years. Results: A total of 566 distinct pathogens were isolated from 523 neonatal bacterial infection cases. Gram-positive bacteria represented the largest proportion (56.5%), with Conclusion: Over the past five years, Gram-positive bacteria have remained the predominant pathogens in NICU infections, with detection rates increasing annually. In contrast, the detection rate of Gram-negative bacteria has decreased. Gram-positive bacteria show high resistance to penicillin, while Gram-negative bacteria exhibit high resistance to third-generation cephalosporins. Additionally, multidrug-resistant strains have been identified. Temporal trend analysis revealed significant increasing trends for

Indexed as

bacterial infectiondrug resistanceneonatal intensive care unitnewbornpathogen

Identifiers

PMID42730318
PMCPMC13564462

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.